Pritzker Private Capital (“PPC”), a leader in family direct investing, today announced the appointment of Paula Brown Stafford to the Pritzker Advisory Board. Ms. Stafford, currently Chairman and CEO of biotechnology company Novan, brings more than 30 years of healthcare industry experience to the Pritzker Advisory Board and PPC’s family of companies. Her appointment will enhance PPC’s initiatives to invest in and partner with market-leading healthcare companies, specifically in healthcare services, medical products, pharmaceutical services and the life sciences supply chain.

Chaired by Tony Pritzker, the Pritzker Advisory Board is a team of eight world-class strategic and operational executives, with diverse skill sets and proven experience leading global organizations. PAB members advise on PPC’s investment strategy, strengthen partnerships with management teams and enhance the firm’s operations capabilities.

“We are pleased to welcome Paula to the Pritzker Advisory Board and the PPC family,” said Michael Dal Bello, Investment Partner – Healthcare at PPC and co-leader of PPC’s Healthcare team. “Paula is a globally recognized leader in the pharmaceutical industry with a proven track record of growth and success. Her deep expertise and strong relationships across the sector will help us continue to identify exciting new partnership opportunities and expand our family of healthcare companies.”

“Paula is a great addition to the Pritzker Advisory Board. Her unique experience, growth mindset and history of value creation will strengthen the operations capabilities PPC provides to its companies,” said David King, Operating Partner – Healthcare at PPC and co-leader of PPC’s Healthcare team. “At PPC, we believe in building businesses for the long term, and I look forward to working closely with Paula as we build value across our family of companies.”

“I am delighted to join the accomplished group of executives that make up the Pritzker Advisory Board,” said Ms. Stafford. “I have long admired PPC’s philosophy, culture and the remarkable Pritzker legacy. I am eager to contribute to the PPC team, identifying new companies that are a compelling fit with PPC’s values and partnering with strong management teams to support their long-term growth.”

Ms. Stafford is currently Chairman and CEO of Novan (Nasdaq: NOVN), an innovative biotechnology company and a leader in developing nitric oxide-based therapies for dermatological, women’s health and infectious diseases. She previously led the clinical development operations division of Quintiles (now IQVIA), one of the world’s largest contract research organizations (CRO). At Quintiles, she oversaw a division that delivered approximately $3 billion of annual revenue, with 22,000 employees across 60 countries. Ms. Stafford serves on the Board of Health Decisions, Inc., and is an emeritus member of the Public Health Foundation Board of the University of North Carolina’s Gillings School of Public Health. She holds a Bachelor of Science and a Master of Public Health, both from the University of North Carolina at Chapel Hill.

In addition to Tony Pritzker as Chairman, members of the Pritzker Advisory Board include the following distinguished business leaders:

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm's differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit PPCPartners.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210720005405/en/